|
| The use of protein phosphatase 2A activators in combination therapies for pancreas cancer |
|
https://doi.org/10.18632/oncotarget.26772
Brittany L. Allen-Petersen, and Rosalie C. Sears
|
| 2008-2009 |
|
| TET2 mutations and clonal dynamics |
|
https://doi.org/10.18632/oncotarget.26779
Ashwin Kishtagari, Babal K. Jha, and Jaroslaw P. Maciejewski
|
| 2010-2011 |
|
| Next generation sequencing driven successful combined treatment with laparoscopic surgery and immunotherapy for relapsed stage IVB cervical and synchronous stage IV lung cancer |
|
https://doi.org/10.18632/oncotarget.26769
Clelia Madeddu, Paraskevas Kotsonis, Fabrizio Lavra, Giacomo Chiappe, Luca Melis, Ester Mura, Mario Scartozzi, and Antonio Macciò
|
| 2012-2021 |
|
| Multi-walled carbon nanotubes complement the anti-tumoral effect of 5-Fluorouracil |
|
https://doi.org/10.18632/oncotarget.26770
Eloisa González-Lavado, Lourdes Valdivia, Almudena García-Castaño, Fernando González, Carmen Pesquera, Rafael Valiente, and Mónica L. Fanarraga
|
| 2022-2029 |
|
| The immune checkpoint molecules PD-1, PD-L1, TIM-3 and LAG-3 in diffuse large B-cell lymphoma |
|
https://doi.org/10.18632/oncotarget.26771
Benjamin J. Chen, Ravi Dashnamoorthy, Pallavi Galera, Vladislav Makarenko, Hong Chang, Srimoyee Ghosh, and Andrew M. Evens
|
| 2030-2040 |
|
| CD164 regulates proliferation, progression, and invasion of human glioblastoma cells |
|
https://doi.org/10.18632/oncotarget.26724
Chung-Ching Wang, Dueng-Yuan Hueng, Ai-Fang Huang, Wei-Liang Chen, Shih-Ming Huang, and James Yi-Hsin Chan
|
| 2041-2054 |
|
| AXL knockdown gene signature reveals a drug repurposing opportunity for a class of antipsychotics to reduce growth and metastasis of triple negative breast cancer |
|
https://doi.org/10.18632/oncotarget.26725
Marie-Anne Goyette, Rebecca Cusseddu, Islam Elkholi, Afnan Abu-Thuraia, Nehme El-Hachem, Benjamin Haibe-Kains, Jean-Philippe Gratton, and Jean-François Côté
|
| 2055-2067 |
|
| HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β |
|
https://doi.org/10.18632/oncotarget.26699
Ken Tawara, Hannah Scott, Jacqueline Emathinger, Cody Wolf, Dollie LaJoie, Danielle Hedeen, Laura Bond, Paul Montgomery, and Cheryl Jorcyk
|
| 2068-2085 |
|
| Dual inhibition of ABCE1 and LCP1 by microRNA96 results in an additive effect in breast cancer mouse model |
|
https://doi.org/10.18632/oncotarget.26747
Nir Pillar, Avital Luba Polsky, and Noam Shomron
|
| 2086-2094 |
|
| Molecular mechanisms and pathobiology of oncogenic fusion transcripts in epithelial tumors |
|
https://doi.org/10.18632/oncotarget.26777
Musaffe Tuna, Christopher I. Amos, and Gordon B. Mills
|
| 2095-2111 |
|
| Correction: HOTAIR regulates HK2 expression by binding endogenous miR125 and miR143 in oesophageal squamous cell carcinoma progression |
|
https://doi.org/10.18632/oncotarget.26801
Jian Ma, Yanxin Fan, Tingting Feng, Fangjun Chen, Zhipeng Xu, Suqing Li, Qingfeng Lin, Xiaoting He, Weihong Shi, Yang Liu, Zhihua Liu, Bin Zhu, and Xiufeng Cao
|
| 2112-2112 |
|
| Erratum: Predicting clinically significant prostate cancer using DCEMRI habitat descriptors |
|
https://doi.org/10.18632/oncotarget.26802
N. Andres Parra, Hong Lu, Qian Li, Radka Stoyanova, Alan Pollack, Sanoj Punnen, Jung Choi, Mahmoud Abdalah, Christopher Lopez, Kenneth Gage, Jong Y. Park, Yamoah Kosj, Julio M. Pow-Sang, Robert J. Gillies, and Yoganand Balagurunathan
|
| 2113-2113 |
